410 related articles for article (PubMed ID: 29027224)
21. Therapy-induced microenvironmental changes in cancer.
Ma Y; Yang H; Pitt JM; Kroemer G; Zitvogel L
J Mol Med (Berl); 2016 May; 94(5):497-508. PubMed ID: 26931513
[TBL] [Abstract][Full Text] [Related]
22. Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential.
Frey B; Stache C; Rubner Y; Werthmöller N; Schulz K; Sieber R; Semrau S; Rödel F; Fietkau R; Gaipl US
J Immunotoxicol; 2012; 9(3):301-13. PubMed ID: 22800185
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta: a master immune regulator.
Larson C; Oronsky B; Carter CA; Oronsky A; Knox SJ; Sher D; Reid TR
Expert Opin Ther Targets; 2020 May; 24(5):427-438. PubMed ID: 32228232
[No Abstract] [Full Text] [Related]
24. Ionizing radiation and toll like receptors: A systematic review article.
Mehdipour A; Yousefi-Ahmadipour A; Kennedy D; Kazemi Arababadi M
Hum Immunol; 2021 Jun; 82(6):446-454. PubMed ID: 33812705
[TBL] [Abstract][Full Text] [Related]
25. [Radiation therapy and immunomodulation: Focus on experimental data].
Deutsch É; Lévy A; Chargari C
Cancer Radiother; 2015 Oct; 19(6-7):515-8. PubMed ID: 26293415
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in the Diagnosis and Treatment of Cancer.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Immunol Invest; 2017 Nov; 46(8):880-897. PubMed ID: 29058545
[TBL] [Abstract][Full Text] [Related]
27. Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.
Cacan E; Spring AM; Kumari A; Greer SF; Garnett-Benson C
Int J Mol Sci; 2015 Dec; 16(12):30405-21. PubMed ID: 26703577
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
Harper J; Sainson RC
Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
[TBL] [Abstract][Full Text] [Related]
29. Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System.
Falcke SE; Rühle PF; Deloch L; Fietkau R; Frey B; Gaipl US
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428512
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum RR; Liang H; Deng L; Fu YX
Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced immune response in novel radiotherapy approaches FLASH and spatially fractionated radiotherapies.
Bertho A; Iturri L; Prezado Y
Int Rev Cell Mol Biol; 2023; 376():37-68. PubMed ID: 36997269
[TBL] [Abstract][Full Text] [Related]
32. Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications.
Bockel S; Durand B; Deutsch E
Cancer Radiother; 2018 Oct; 22(6-7):567-580. PubMed ID: 30197026
[TBL] [Abstract][Full Text] [Related]
33. Immunological effects of chemotherapy and radiotherapy against brain tumors.
Weiss T; Weller M; Roth P
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1087-94. PubMed ID: 27598516
[TBL] [Abstract][Full Text] [Related]
34. High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities.
Cirincione R; Di Maggio FM; Forte GI; Minafra L; Bravatà V; Castiglia L; Cavalieri V; Borasi G; Russo G; Lio D; Messa C; Gilardi MC; Cammarata FP
Ultrasound Med Biol; 2017 Feb; 43(2):398-411. PubMed ID: 27780661
[TBL] [Abstract][Full Text] [Related]
35. Role of Local Radiation Therapy in Cancer Immunotherapy.
Demaria S; Golden EB; Formenti SC
JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
[TBL] [Abstract][Full Text] [Related]
36. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
[TBL] [Abstract][Full Text] [Related]
37. Optimizing Radiotherapy with Immunotherapeutic Approaches.
Schoenhals JE; Skrepnik T; Selek U; Cortez MA; Li A; Welsh JW
Adv Exp Med Biol; 2017; 995():53-71. PubMed ID: 28321812
[TBL] [Abstract][Full Text] [Related]
38. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
39. Damage-associated molecular patterns in tumor radiotherapy.
Ashrafizadeh M; Farhood B; Eleojo Musa A; Taeb S; Najafi M
Int Immunopharmacol; 2020 Sep; 86():106761. PubMed ID: 32629409
[TBL] [Abstract][Full Text] [Related]
40. Turning "Cold" Into "Hot" Tumors-Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers.
Sevenich L
Front Oncol; 2019; 9():163. PubMed ID: 30941312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
